Accuray Inc. Files 8-K on Financials
Ticker: ARAY · Form: 8-K · Filed: Aug 14, 2024 · CIK: 1138723
| Field | Detail |
|---|---|
| Company | Accuray INC (ARAY) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: ACCY
TL;DR
Accuray dropped an 8-K on financials, check it out.
AI Summary
Accuray Incorporated filed an 8-K on August 14, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 1240 Deming Way, Madison, Wisconsin.
Why It Matters
This 8-K filing provides crucial updates on Accuray's financial performance and operational status, which can influence investor decisions.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing and does not indicate any immediate or significant risks.
Key Players & Entities
- ACCURAY INC (company) — Filer
- Delaware (jurisdiction) — State of Incorporation
- 1240 Deming Way, Madison, Wisconsin (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Accuray Incorporated's results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on August 14, 2024.
Where are Accuray Incorporated's principal executive offices located?
Accuray Incorporated's principal executive offices are located at 1240 Deming Way, Madison, Wisconsin, 53717-1954.
What is Accuray Incorporated's Commission File Number?
Accuray Incorporated's Commission File Number is 001-33301.
What is the Standard Industrial Classification code for Accuray Incorporated?
The Standard Industrial Classification code for Accuray Incorporated is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 800 words · 3 min read · ~3 pages · Grade level 11.3 · Accepted 2024-08-14 16:03:11
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share ARAY The Nasdaq
Filing Documents
- aray-20240814.htm (8-K) — 45KB
- aray-ex99_1.htm (EX-99.1) — 344KB
- aray-ex99_2.htm (EX-99.2) — 13KB
- img235950492_0.jpg (GRAPHIC) — 18KB
- aray-ex99_2s1.jpg (GRAPHIC) — 140KB
- aray-ex99_2s2.jpg (GRAPHIC) — 964KB
- aray-ex99_2s3.jpg (GRAPHIC) — 352KB
- aray-ex99_2s4.jpg (GRAPHIC) — 311KB
- aray-ex99_2s5.jpg (GRAPHIC) — 456KB
- aray-ex99_2s6.jpg (GRAPHIC) — 322KB
- aray-ex99_2s7.jpg (GRAPHIC) — 438KB
- aray-ex99_2s8.jpg (GRAPHIC) — 216KB
- aray-ex99_2s9.jpg (GRAPHIC) — 132KB
- aray-ex99_2s10.jpg (GRAPHIC) — 319KB
- aray-ex99_2s11.jpg (GRAPHIC) — 338KB
- aray-ex99_2s12.jpg (GRAPHIC) — 304KB
- 0000950170-24-096978.txt ( ) — 6468KB
- aray-20240814.xsd (EX-101.SCH) — 23KB
- aray-20240814_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 14, 2024, Accuray Incorporated (the "Company") issued a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2024. A copy of the Company's press release dated August 14, 2024, titled "Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results" is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information (including the exhibit hereto) is being furnished under "Item 2.02 Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), except as shall be expressly set forth by specific reference in such filing.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Spokespersons of the Company plan to present the information in the presentation attached hereto as Exhibit 99.2 to analysts and investors from time to time on or after August 14, 2024. The presentation will be available on the Company's Investor Relations website at: http://investors.accuray.com. The furnishing of the attached presentation is not an admission as to the materiality of any information therein. The information contained in the presentation is summary information that is intended to be considered in the context of more complete information included in the Company's filings with the U.S. Securities and Exchange Commission and other public announcements that the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report. For important information about forward looking statements, see the slide titled "Forward-Looking Statements" in Exhibit 99.2 attached hereto. The information set forth under Item 2.02 of this Current Report on Form 8-K is incorporated by reference into this Item 7.01. The information contained in this Item 7.01 disclosure, including Exhibit 99.1 and Exhibit 99.2, is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated August 14, 2024, titled "Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results" 99.2 Accuray Fourth Quarter and Fiscal 2024 Earnings Call Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ACCURAY INCORPORATED Date August 14, 2024 By: /s/ Ali Pervaiz Ali Pervaiz Senior Vice President & Chief Financial Officer 3